Docoh
Loading...

26 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
), neither (A) the Time of Sale Disclosure Package (as defined below) nor (B) any issuer free writing prospectus (as defined below), when considered … together with the Time of Sale Disclosure Package, included an untrue statement of a material fact or omitted to state a material fact necessary in order
S-1/A
EX-1.1
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
of Sale Disclosure Package (as defined below) nor (B) any issuer free writing prospectus (as defined below), when considered together with the Time … of Sale Disclosure Package, included an untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements
8-K
EX-99.1
PCSA Processa Pharmaceuticals Inc
28 Oct 14
Entry into a Material Definitive Agreement
8:00pm
the right to design and employ such promotional materials including, without limitation, any packaging, labeling, advertising. marketing, package
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
effective compensation package for our named executive officers is one designed to reward achievement of individual and corporate objectives; provide
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
the Compound and Products in the Field in the Territory, including: pre-IND briefing package, reports and documentation related to Clinical Trials
8-K
9v2vgk8inobry
11 Oct 17
Entry into a Material Definitive Agreement
8:00pm
8-K/A
0nhqki
16 Oct 17
Entry into a Material Definitive Agreement
8:00pm
10-K
jkjttlm30
5 Mar 20
Annual report
7:00pm
10-K
56y6f3
18 Jun 17
Annual report
8:00pm
DEF 14A
jfv8ukjq
22 Apr 21
Definitive proxy
2:00pm
10-K
pcglos3y
13 Apr 15
Annual report
8:00pm
S-1
ul8wnkj
13 Dec 19
IPO registration
5:32pm
10-K/A
t472sdey8rr r9h7nm93
5 Apr 19
Annual report (amended)
9:40pm
10-K
cbc9 zaoix
28 Mar 19
Annual report
5:25pm
10-K/A
5h4dbop
16 Apr 18
Annual report (amended)
8:00pm
10-K
0vjev x8d8e
15 Apr 18
Annual report
8:00pm
10-K
vlhnayrn96gj2a4wuq4
24 Mar 21
Annual report
8:00pm
S-1
8kh0qy6vw7o
29 Jul 18
IPO registration
8:00pm
S-1/A
t965e84m npbjt
13 Sep 18
IPO registration (amended)
8:00pm
424B3
fd2ujhx1twub6mag aq
9 Nov 18
Prospectus supplement
5:04pm